Area of expertise: Congenital heart disease, heart development, cell fate decisions, gene regulation, epigenetic regulation, non-coding DNA, molecular biology, transgenic mouse models, pluripotent stem cells
Dr Stefanovic received her PhD in Molecular and Cellular Biology at the Institute for Stem cell Therapy and Exploration of Monogenic diseases (ISTEM) in the Paris district in 2009 (Dr Puceat’s lab). She then worked as a postdoctoral research scientist at the University of Amsterdam, at the Academic Medical Center (Prof Christoffels lab) and at the Marseille Medical Genetics (MMG) center (Dr Zaffran's lab). Dr Stefanovic was recruited as a permanent researcher by the French National Institute for Health and Medical Research (INSERM) in 2016. Since 2022, she is leading a research group at the CardioVascular and Nutrition research center (C2VN).
Since the beginning of her career, Dr Stefanovic has been interested in the molecular mechanisms involved in cardiac development in order to clarify the genetic basis of congenital heart defects. For the last 12 years, she has been working on the role of non-coding DNA sequences during cardiogenesis. She discovered that some cardiac regulatory elements act as cell-type-specific switches. During her PhD, she was trained on early cardiac fate specification during pluripotent stem cell differentiation (mouse, human ES and iPS cells). During her post-doctoral training, she used a complementary in vivo model (mouse transgenic embryos), to understand how cardiac progenitors become specialized and differentiate into pacemaker cells. Dr Stefanovic has a high level of expertise in manipulating transgenic mice and characterizing the function and phenotype of disease models of congenital heart defects, a strong expertise in dissecting regulatory elements through a wide range of novel experimental methods in molecular biology such as transcriptomics, epigenomics (RNA-seq, ATAC-seq, ChIP-seq), as well as in pluripotent stem cell-derived cardiomyocytes to model the early steps of cardiogenesis. Currently she is leading research projects on maternal dietry during pregnancy and congenital heart defects.
She was granted the European Molecular Biology Organization fellowship (2010), the European Society of Cardiology research grant (2013), the Lefoulon-Delalande grant (2014) the European Marie-Curie Fellowship (2014), the ERA-CVD (2019, 250 k€) grant and the ANR-JCJC (2020, 240 k€) allowing her to form her own research group.
Number of publications: total: 22, as first author: 10 (including 6 peer-reviewed scientific publications and 7 reviews)
Best 5 selected peer-reviewed scientific publications:
STEFANOVIC S*, Laforest B*, Desvignes JP, Lescroart F, Argiro L, Maurel-Zaffran C, Salgado D, Plaindoux E, De Bono C, Pazur K, Théveniau-Ruissy M, Béroud C, Puceat M, Gavalas A, Kelly RG, ZAFFRAN S. Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation. Elife. 2020 PMID: 32804075 IF 8
van Eif VWW*, STEFANOVIC S*, van Duijvenboden K, Bakker M, Wakker V, de Gier-de Vries C, Zaffran S, Verkerk AO, Boukens BJ, CHRISTOFFELS VM. Transcriptome analysis of mouse and human sinoatrial node cells reveals a conserved genetic program. Development. 2019 PMID: 30936179 IF 6
STEFANOVIC S, Barnett P, van Duijvenboden K, Weber D, Gessler M, CHRISTOFFELS VM. GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development. Nat Commun. 2014 PMID: 24770533 IF 12
Blin G*, Nury D*, STEFANOVIC S*, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, PUCÉAT M (2010). A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. The Journal of Clinical Investigation PMID: 20335662 IF 13
STEFANOVIC S, Abboud N, Désilets S, Nury D, Cowan C, PUCÉAT M (2009). Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. The Journal of Cell Biology. PMID: 19736317 IF 9
*co-first author